Skip to main content
TruScreen Group Limited logo

TruScreen Group Limited — Investor Relations & Filings

Ticker · TRU ISIN · NZTRUE0001S7 NZX Manufacturing
Open in API
Filings indexed 367 across all filing types
Latest filing 2020-04-27 Investor Presentation
Country NZ New Zealand
Listing NZX TRU

About TruScreen Group Limited

https://www.truscreen.com

TruScreen Group Limited develops and manufactures a proprietary cervical cancer screening system that utilizes opto-electrical technology for the real-time detection of precancerous and cancerous tissue. The system employs a single-use sensor to measure tissue response to specific electrical and optical stimuli, processing the data through an integrated algorithm to provide an immediate objective result. By eliminating the requirement for laboratory processing, tissue sampling, and specialized pathology infrastructure, the technology facilitates point-of-care screening in diverse clinical environments. The device is designed to address the limitations of traditional cytology, offering a non-invasive, portable solution that enhances the efficiency of screening programs and improves patient access to diagnostic results.

Recent filings

Filing Released Lang Actions
Truscreen Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'INVESTOR PRESENTATION April 2020' and contains detailed information about the company's product, market, financial overview, growth strategy, key markets, milestones, and executive team. It includes charts, financial data summaries, and strategic plans typical of a presentation aimed at investors. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The content is consistent with an investor presentation, which is a detailed presentation for investors focusing on financials, strategy, and market position.
2020-04-27 English
Share Purchase Plan Offer Document and Application Form
Capital/Financing Update Classification · 95% confidence The document is titled 'SHARE PURCHASE PLAN BOOKLET' and is dated 28 April 2020. It contains detailed information about an offer of new ordinary shares to eligible shareholders, including terms and conditions, eligibility criteria, application procedures, issue price, and key dates for the offer. The content focuses on a fundraising activity through a share purchase plan, describing how shareholders can subscribe for new shares, the pricing, and the use of funds. There is no indication that this is a financial report, earnings release, or regulatory filing. Instead, it is an update on capital raising and financing activities. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual booklet and not just an announcement or notice.
2020-04-27 English
Truscreen announces $2 million Share Purchase Plan
Capital/Financing Update Classification · 95% confidence The document is an announcement from TruScreen Limited about the opening of a $2.0 million Share Purchase Plan (SPP). It details the offer price, eligibility, key dates for the offer, and the intended use of funds raised. It also mentions accompanying documents like the Corporate Action Notice, Cleansing Notice, Offer Document, Application Form, and Investor Presentation. The content focuses on fundraising and capital raising activities rather than financial results, management changes, or regulatory filings. The document length is 3379 characters, which is relatively short and primarily an announcement rather than a detailed report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-04-27 English
TRU expands to Vietnam with Ministry of Health Approval
Regulatory Filings Classification · 95% confidence The document is an announcement dated 20 April 2020 from TruScreen Limited regarding the approval from the Vietnam Ministry of Health for commercial rollout of their cervical cancer screening device. It describes the clinical trial results and the significance of the approval. There are no financial statements, regulatory filings, or detailed financial data. The document is a company announcement about a business development or product approval, not a financial report or regulatory filing. It is relatively short (3605 characters) and serves as a news update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and company news that do not fit other specific categories.
2020-04-19 English
Market Update
Capital/Financing Update Classification · 90% confidence The document is an announcement titled 'TruScreen Market Update' dated 9 April 2020. It provides updates on the company's commercial operations, impact of COVID-19 on device rollout, operational changes, R&D funding received, and a forecast for the financial year ended 31 March 2020. The document does not contain detailed financial statements or comprehensive financial analysis but rather a summary and forecast. It also mentions corporate changes such as board reduction and directors receiving fees in shares, but this is part of the market update rather than a formal management or board change announcement. The document is about operational and market status updates, funding received, and forecast results, which aligns best with a Capital/Financing Update (CAP) as it includes R&D funding and financial forecasts related to capital and operations. It is not a full annual or interim report, nor a regulatory filing or earnings release. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-04-08 English
Resignation of Director
Board/Management Information Classification · 100% confidence The document is an announcement dated 1 April 2020 regarding the resignation of a director, Dr. Ron Jones, from the board of TruScreen Limited. It details his contributions and the resulting changes in the board and Medical Advisory Committee. There is no financial data, no mention of financial results, reports, or regulatory filings. The content focuses solely on management/board changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or certification, so it is not RPA or RNS.
2020-04-01 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.